Losartan Potassium
Product Images NDC 50090-4048

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-4048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph comparing the percentage of patients with the primary endpoint over study months for Atenolol and Losartan potassium. Atenolol is represented by a dotted line, and Losartan potassium by a solid line. The graph shows adjusted risk reduction data with time on the x-axis (0 to 66 months) and percentage of patients on the y-axis (0 to 16%).*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over study months for Atenolol and Losartan potassium. Atenolol is represented by a dotted line showing higher rates, while Losartan potassium is shown with a solid line indicating lower rates. The graph notes an adjusted risk reduction of 25% for Losartan potassium with p=0.001.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart showing hazard ratios with 95% confidence intervals comparing event rates between Losartan Potassium and Atenolol treatments. It includes data subdivided by patient demographics (age, gender, race) and medical history (ISH, diabetes, history of CVD) for primary composite and stroke (fatal/non-fatal) outcomes, indicating which treatment is favored in each subgroup.*

FDA Label Image

Figure4 (Figure4)

A line graph comparing the percentage of patients with an event over 48 months between Losartan potassium and placebo groups. The x-axis represents time in months, and the y-axis shows the percentage of patients with an event. The graph indicates risk reduction and a p-value for statistical significance.*

FDA Label Image

Label Image (Lbl500904048)

LOSARTAN POTASSIUM 100 mg packaging label from A-S Medication Solutions, showing product NDC 50090-4048. The label states the package contains 90 tablets and includes storage instructions to keep at 77 degrees Fahrenheit, protecting from light. It features dosage, lot number, and manufacturing information along with a barcode.*

FDA Label Image

Structural-formula (Structural Formula)

Chemical structure diagram of the active ingredient losartan potassium showing its molecular components, including rings, chlorine atom, hydroxyl group, and potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.